# Codex Phase 2 EXIT Review — 2026-05-01

**Review fired:** 2026-05-01 (Phase 2 exit gate)
**Reviewer:** Codex (gpt-5.5 via OpenAI Codex CLI v0.125.0)
**Scope:** Master PRD v1.10 — all 7 architectural shifts (C1–C7) end-to-end
**Cycles:** 3 (v0.1 initial fire + v0.2 verification + v0.3 micro-patch verification)

---

## Bottom line (verbatim)

> "**Bottom line: Phase 2 ready to declare CLOSED.** The two v0.3 patches are sufficient to close MEDIUM-1. I verified lines 488 and 490 now use `Telecheck-US` tenant framing with `Heros Health DBA` only as consumer-brand context. The old unqualified `Heros Health programs` / `Heros US GLP-1` wording is gone. No new HIGH or MEDIUM findings created. Remaining `Heros` references appear contextual, historical, DBA, or glossary-governed."

**🟢 STATUS: 0 HIGH / 0 MEDIUM. PHASE 2 CLEARED FOR CLOSURE.**

---

## v0.1 fire — findings (verbatim)

> "**HIGH — Heros migration scope is still contradictory.** v1.10 says migration was removed: line 68 'Heros migration removed from scope,' line 92 strikeout, and §21 line 946 makes 'Heros migration from Rimo Health' a non-goal. But canonical sections still include it as launch/deferred work: line 252 'One-time Heros migration is a launch-scope engineering project,' line 279 'Heros Migration project,' line 283 'Heros migration data-quality discovery,' line 554 'For Heros migration,' and line 833 'Heros migration tooling productization.' This blocks Phase 2 exit."

> "**MEDIUM — C3 brand/tenant language is not fully canonical.** Line 100 says 'Two consumer brands launch,' conflicting with Heros Health as one global consumer DBA country-instanced. Lines 157, 317, 418, 812, 970, 984, 1022, 1049, and 1072 still use 'Heros' as if it is a tenant/operator/payment party/team rather than `Telecheck-US` / Telecheck Health LLC DBA Heros Health."

> "**MEDIUM — §13.2 is implemented, but downstream references are stale.** §25 line 1079 still says the working definition is needed. §24 line 1059 says 'US=false' instead of the canonical enum value `prohibited`."

> "**MEDIUM — Glossary forbidden aliases remain in canonical sections.** `prescription` appears repeatedly... `customer` appears at lines 424 and 822. No `chatbot` found."

## v0.2 patches applied

**HIGH fix — Heros migration cleanup (5 substantive edits):**
- §5.2 Capabilities deferred — deleted "Heros migration tooling productization" bullet entirely.
- §6 Timeline table — deleted "Heros Migration project | 4 weeks" row entirely; updated narrative to reference greenfield Telecheck-US patient acquisition lead time only.
- §12 Launch readiness — replaced "For Heros migration, equivalent US Launch Playbook..." with "For Telecheck-US (greenfield launch under the Heros Health DBA per §change-log v1.7 #14)..."
- §19 Phase 2 roadmap — deleted "Heros migration tooling productization" bullet entirely.
- Remaining migration references retained: change-log entries (historical); §21 non-goal entry (correct framing); §23 risk register (correct framing); §24 row 1 (DECIDED row); v1.8 historical change-log.

**MEDIUM-1 fix — C3 brand normalization (15+ edits):**
- Line 100 reframe: "Two consumer brands launch" → "Two operating tenants launch on the platform under one country-instanced consumer brand (Heros Health, surfaced as `heroshealth.com` in the US and `ghana.heroshealth.com` in Ghana)"
- 14 additional Heros-as-tenant/operator references replaced with `Telecheck-US` (operating tenant) / `Telecheck Health LLC` (legal entity) / `Heros Health DBA` (consumer-brand qualifier) where each is appropriate.

**MEDIUM-2 fix — §24/§25 stale refs:**
- §24 row 18: "US=false, Ghana=pending regulatory engagement" → canonical 3-state enum: `molecule_level_marketing_permitted = prohibited` for US, `pending_evidence` for Ghana, with explicit FDA + state telehealth advertising rationale.
- §25 Q13 reframed: working definition is canonical in §13.2 (5-criteria + fail-closed); open question becomes borderline-case refinement under §13.2 Governance review process.

**MEDIUM-3 fix — Glossary forbidden aliases (entity-alias cleanup + §17 contextual carve-out):**
- Pillar 3 "Pharmacy and prescription commerce" → "Pharmacy and medication-fulfillment commerce" (2 occurrences).
- "per-prescription medication margin" / "per-prescription margin" → "per-medication-fulfillment margin" (2 occurrences).
- §13.7 I-012 preservation rule: "For prescription, refill, and medication-order actions" → "For `medication_request` (prescription), refill, and medication-order actions governed by I-012 (per the canonical INVARIANTS contract entry 'I-012 prescription sign-off')"
- §17 NEW carve-out paragraph: enumerates permitted contextual exceptions for "prescription" (canonical INVARIANTS name; FDA / regulatory literal phrases; Stripe payment-platform terms) and "customer" (Stripe / Paystack admin literal entity; standard business terms with no platform-entity meaning). Plus a "Heros" → operating-tenant-naming rule.

## v0.2 verification (verbatim)

> "1. **HIGH Heros migration:** closed. Remaining migration refs are historical/decision/risk framing and no longer imply productized migration scope.
> 2. **MEDIUM-1 C3 brand normalization:** mostly closed, but **not fully**. Residual canonical current-scope hits: line 488 'does Heros add chronic care to its catalog?'; line 490 'Heros US GLP-1'.
> 3. **MEDIUM-2 §24/§25:** closed. Row 18 now uses the enum correctly; Q13 is now borderline refinement, not missing definition.
> 4. **MEDIUM-3 aliases:** closed. The §17 carve-outs are reasonable. I would not go stricter; they distinguish platform entities from legal/regulatory/payment/business terms cleanly.
> 5. **New HIGH/MEDIUM:** no new HIGH. Only residual MEDIUM-1 cleanup above."

## v0.3 micro-patches (lines 488 / 490)

- Line 488 "Heros Health programs (GLP-1, ED, hair loss, skincare) are portable... contingent on tenant-strategy decision (does Heros add chronic care to its catalog?)" → "Telecheck-US (Heros Health DBA) programs (GLP-1, ED, hair loss, skincare) are portable... contingent on tenant-strategy decision (does the Telecheck-US tenant operator add chronic care to its catalog?)"
- Line 490 "Program Porting Checklist (Heros US GLP-1 → Telecheck-Ghana GLP-1)" → "Program Porting Checklist (Telecheck-US GLP-1 [Heros Health DBA] → Telecheck-Ghana GLP-1 [Heros Health Ghana DBA])"

## v0.3 verification — clearance reasoning (verbatim)

> "Yes. The two v0.3 patches are sufficient to close MEDIUM-1. I verified lines 488 and 490 now use `Telecheck-US` tenant framing with `Heros Health DBA` only as consumer-brand context. The old unqualified `Heros Health programs` / `Heros US GLP-1` wording is gone. No new HIGH or MEDIUM findings created. Remaining `Heros` references appear contextual, historical, DBA, or glossary-governed. Bottom line: Phase 2 ready to declare CLOSED."

## Convergence trajectory — Phase 2 EXIT

| Cycle | Findings | Action |
|---|---|---|
| v0.1 (initial fire) | 1 HIGH (Heros migration) + 3 MEDIUM (C3 brand, §24/§25 stale, alias discipline) | All 4 patched |
| v0.2 (verification fire) | 0 HIGH + 1 residual MEDIUM-1 (lines 488/490) | 2-line micro-patch |
| **v0.3 (re-verification)** | **0 HIGH / 0 MEDIUM. CLOSED.** | Phase 2 declared closed |

## Matrix update applied

7 Master PRD rows advanced from "Not started" → **Approved**:

| Row | Cycle | Section coverage |
|---|---|---|
| 2 | C1 | §21 Non-goals regulatory-conditional rewrite |
| 6 | C2 | §1, §6, §7.8, §8, §9.3, §16, §18.5, §20, §21, §23, §25 emerging-markets reframe |
| 17 | C3 | §1, §2, §4, §10.1, §18.3, §19, §25 brand structure cascade |
| 46 | C4 | §7.9, §13.2, §21 marketing posture |
| 57 | C5 | §7.10, §15.2, §15.3, §18, §22, §24 research data partnership |
| 82 | C6 | §10.5 program catalog architecture |
| 99 | C7 | §13.7 AI workload taxonomy |

Sentinel row 109 updated with Phase 2 close declaration.

Cumulative matrix status after Phase 2 close: 11 Approved, 3 Edited (F02 ADR Set Index pre-staged for Phase 5), 93 Not started, 1 None.

## Phase 2 next-step ordering

Per planning freeze v1.6 §3 Phase 2 exit criteria, Phase 2 is now closed. Next phase per the §1 ordering rule:

→ **Phase 3 — Contracts Pack edits.** Contracts Pack v5.1 files: AUDIT_EVENTS, DOMAIN_EVENTS, ERROR_MODEL, IDEMPOTENCY, GLOSSARY (already approved at Phase 2.X), CCR_RUNTIME, AI_LAYERING, FORMS_ENGINE, MARKET_LAUNCH, GOVERNANCE_CONTROLS, TYPES, INVARIANTS, plus the new contracts WORKLOAD_TAXONOMY and AUTONOMY_LEVELS (currently DRAFT in `Telecheck_v1_10_PRD_Update/`).

Each contract follows the same convergence pattern: draft (already done for new ones) → reconcile against canonical Master PRD v1.10 + ADRs → fire Codex per contract or per logical group → patch → converge → matrix advance.

## Document control

- **v1.0 — 2026-05-01** — Codex Phase 2 EXIT review across all 7 cycles. 3-cycle convergence: v0.1 (1 HIGH + 3 MEDIUM) → v0.2 (0 HIGH + 1 residual MEDIUM-1) → v0.3 (0 HIGH + 0 MEDIUM, CLOSED). Master PRD v1.10 canonicalized for Phase 2 scope. 7 matrix rows (2, 6, 17, 46, 57, 82, 99) advanced to Approved.
- **Companion artifacts:** `Telecheck_Master_Platform_PRD_v1_10.md` (canonicalized through Phase 2); `Codex_Phase2_MidCycle_Review_v0_2_2026-05-01.md` (§13.7 mid-cycle review); `Codex_Phase2X_F13_Glossary_Reconciliation_Review_2026-05-01.md` (Phase 2.X glossary review).
- **Status:** Delta artifact. **Phase 2 CLOSED.** Phase 3 (Contracts Pack edits) begins.
